Ecrosnes, France

Michel Perricaudet

USPTO Granted Patents = 38 

 

Average Co-Inventor Count = 3.9

ph-index = 14

Forward Citations = 507(Granted Patents)


Location History:

  • Ouarville, FR (2000)
  • 28320 Ecrosnes, FR (2003)
  • Paris, FR (2002 - 2004)
  • Ecrignolles, FR (2004 - 2007)
  • Escrosnes, FR (2014)
  • Ecrosnes, FR (1998 - 2018)

Company Filing History:


Years Active: 1998-2018

Loading Chart...
Loading Chart...
38 patents (USPTO):Explore Patents

Title: Michel Perricaudet - Innovator in Gene Therapy and Vaccines

Introduction

Michel Perricaudet, hailing from Ecrosnes, France, is a prominent inventor in the field of gene therapy and vaccine development. With an impressive portfolio of 38 patents, Perricaudet has significantly contributed to the advancement of medical technologies that aim to strengthen immune responses and combat tumors.

Latest Patents

Among his notable recent inventions is a groundbreaking adenovirus vaccine vector. This invention relates to recombinant adenoviruses that display one or more heterologous epitopes on their fiber protein. These innovative recombinant adenoviruses are designed to be utilized as vaccines for eliciting immune responses against specific epitopes, even in individuals who possess pre-existing anti-Ad immunity. Additionally, he developed recombinant adenoviruses that encode the specific iodine transporter (NIS), which holds potential in the realm of gene therapy and tumor treatment.

Career Highlights

Michel Perricaudet has had an illustrious career, including pivotal roles at prominent pharmaceutical companies such as Aventis Pharma S.A. and Rhone-Poulenc Rorer S.A. His tenure in these organizations has allowed him to push the boundaries of medical research and innovation, with several noteworthy contributions leading to patented technologies.

Collaborations

Throughout his career, Perricaudet has collaborated with distinguished colleagues, including Emmanuelle Vigne and Patrice Yeh. These partnerships have fostered an environment of innovation and shared expertise that has propelled forward the objectives in gene therapy and vaccine development.

Conclusion

In conclusion, Michel Perricaudet stands out as a key figure in the fields of gene therapy and vaccines, with his extensive patent portfolio reflecting his dedication to advancing medical science. His inventive spirit and collaboration with other experts continue to pave the way for breakthroughs that have the potential to improve the lives of many individuals around the globe.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…